Skip to main content
Erschienen in: Diabetologia 8/2005

01.08.2005 | Research Letter

Diabetic cardiomyopathy in uncomplicated type 2 diabetes is associated with the metabolic syndrome and systemic inflammation

verfasst von: M. Diamant, H. J. Lamb, J. W. A. Smit, A. de Roos, R. J. Heine

Erschienen in: Diabetologia | Ausgabe 8/2005

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor: Even in the absence of hypertension or coronary artery disease, type 2 diabetic patients show myocardial structural and functional changes that are ascribed to so-called diabetic cardiomyopathy [1, 2]. Changes in cardiac energy metabolism, resulting from altered myocardial substrate supply and utilisation, in association with insulin resistance, may underlie this condition [3, 4]. In addition to linking insulin resistance, obesity, diabetes and cardiovascular disease, systemic inflammation has been implicated in cardiac functional and structural abnormalities [5, 6]. We hypothesised that cardiac functional changes in subjects with uncomplicated type 2 diabetes may be associated with a number of features of the metabolic syndrome, as defined by National Cholesterol Education Program guidelines [7], and markers of systemic inflammation. To this purpose, using magnetic resonance imaging, we determined cardiac systolic and diastolic function in 13 asymptomatic normotensive men with recently diagnosed (<5 years), well-controlled type 2 diabetes (mean age 56±6 years, HbA1c 6.1±1.1%, mean diabetes duration 14 months [range 6–60 months]) and 13 age-matched controls [2]. Patients had no history or symptoms of cardiovascular disease and all subjects had a normal ECG. Exclusion criteria were microalbuminuria, retinopathy and autonomic neuropathy, as evaluated by Ewing’s cardiovascular tests, and the use of insulin or drugs other than oral hypoglycaemic agents. Plasma TNF-α and IL-6 concentrations and high-sensitivity C-reactive protein (CRP) were determined by ELISAs. Because of non-normal distribution, the inflammatory markers were logarithmically transformed. In addition, a systemic inflammation index was calculated as the sum of the logarithms of these inflammatory markers. The protocol conformed with the principles outlined by the Declaration of Helsinki and was approved by the local ethics committee. All subjects gave written informed consent. Comparisons between groups were made by unpaired two-tailed Student’s t-test. Results are presented as means±SD or as medians (interquartile range). …
Literatur
1.
Zurück zum Zitat Bell DS (1995) Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease? Diabetes Care 18:708–714PubMed Bell DS (1995) Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease? Diabetes Care 18:708–714PubMed
2.
Zurück zum Zitat Diamant M, Lamb HJ, Groeneveld Y et al (2003) Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes. J Am Coll Cardiol 42:328–335CrossRefPubMed Diamant M, Lamb HJ, Groeneveld Y et al (2003) Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes. J Am Coll Cardiol 42:328–335CrossRefPubMed
3.
Zurück zum Zitat Taegtmeyer H, McNulty P, Young ME (2002) Adaptation and maladaptation of the heart in diabetes: Part I. General concepts. Circulation 105:1727–1733CrossRefPubMed Taegtmeyer H, McNulty P, Young ME (2002) Adaptation and maladaptation of the heart in diabetes: Part I. General concepts. Circulation 105:1727–1733CrossRefPubMed
4.
Zurück zum Zitat Iozzo P, Chareonthaitawee P, Dutka D, Betteridge DJ, Ferrannini E, Camici PG (2002) Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes 51:3020–3024PubMed Iozzo P, Chareonthaitawee P, Dutka D, Betteridge DJ, Ferrannini E, Camici PG (2002) Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes 51:3020–3024PubMed
5.
Zurück zum Zitat Festa A, D’Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the IRAS study. Circulation 102:42–47PubMed Festa A, D’Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the IRAS study. Circulation 102:42–47PubMed
6.
Zurück zum Zitat Vasan RS, Sullivan LM, Roubenoff R et al (2003) Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 107:1486–1491CrossRefPubMed Vasan RS, Sullivan LM, Roubenoff R et al (2003) Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 107:1486–1491CrossRefPubMed
7.
Zurück zum Zitat Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (2001) Executive summary of the third report of the NCEP expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 285:2486–2497PubMed Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (2001) Executive summary of the third report of the NCEP expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 285:2486–2497PubMed
8.
Zurück zum Zitat Nicoletti A, Michel JB (1999) Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors. Cardiovasc Res 41:532–543CrossRefPubMed Nicoletti A, Michel JB (1999) Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors. Cardiovasc Res 41:532–543CrossRefPubMed
Metadaten
Titel
Diabetic cardiomyopathy in uncomplicated type 2 diabetes is associated with the metabolic syndrome and systemic inflammation
verfasst von
M. Diamant
H. J. Lamb
J. W. A. Smit
A. de Roos
R. J. Heine
Publikationsdatum
01.08.2005
Erschienen in
Diabetologia / Ausgabe 8/2005
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1821-4

Weitere Artikel der Ausgabe 8/2005

Diabetologia 8/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.